| > The insane margins of insulin are actually split between Lilly, PBMs (like optumRX and CareMark) and insurance companies, through an incredibly complex system of rebates and vouchers. Turning over that rock reveals more writhing maggots than anyone cares to see. Health insurance companies (parent companies of PBMs) have low single digit profit margins, and medicine manufacturers like Eli Lilly have 20%+ profit margins. If health insurance companies are getting any piece of the "insane" profit margin, then it is being eaten up by losses of other healthcare spend. Health insurance company profit margins: https://www.macrotrends.net/stocks/charts/UNH/unitedhealth-g... https://www.macrotrends.net/stocks/charts/ELV/elevance-healt... https://www.macrotrends.net/stocks/charts/CVS/cvs-health/pro... https://www.macrotrends.net/stocks/charts/CI/cigna/profit-ma... https://www.macrotrends.net/stocks/charts/HUM/humana/profit-... Versus medicine manufacturers' profit margins: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnso... https://www.macrotrends.net/stocks/charts/LLY/eli-lilly/prof... https://www.macrotrends.net/stocks/charts/PFE/pfizer/profit-... https://www.macrotrends.net/stocks/charts/NVO/novo-nordisk/p... https://www.macrotrends.net/stocks/charts/ABBV/abbvie/profit... |